Esther D Kim1, Hirofumi Tanaka2, Shoshana H Ballew1, Yingying Sang3, Gerardo Heiss4, Josef Coresh1, Kunihiro Matsushita5. 1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD. 2. Department of Kinesiology and Health Education, University of Texas at Austin, Austin, TX. 3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 4. Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC. 5. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD. Electronic address: kmatsus5@jhmi.edu.
Abstract
RATIONALE & OBJECTIVE: Arterial stiffness is suggested as a mediator of cardiorenal interaction. However, previous studies reported inconsistent associations between chronic kidney disease (CKD) and arterial stiffness and were limited by using either estimated glomerular filtration rate (eGFR) or albumin-creatinine ratio (ACR) and examining arterial stiffness at limited segments. STUDY DESIGN: Cross-sectional. SETTING & PARTICIPANTS: 3,424 Atherosclerosis in Communities (ARIC) Study participants aged 66 to 90 years during 2011 to 2013. PREDICTORS: eGFR and ACR. OUTCOME: Pulse wave velocity (PWV) at 6 segments: carotid-femoral (cfPWV), heart-carotid (hcPWV), and heart-femoral (hfPWV), reflecting central stiffness; heart-ankle (haPWV) and brachial-ankle (baPWV), representing both central and peripheral stiffness; and femoral-ankle (faPWV), indicating peripheral stiffness. ANALYTICAL APPROACH: Multiple linear and logistic regression models to quantify the associations of eGFR and ACR with continuous PWV and elevated PWV (in the highest quartile), respectively. RESULTS: After adjusting for age, sex, and race, higher cfPWV and hfPWV were consistently associated with lower eGFR and higher ACR. Higher haPWV and baPWV were also observed with higher ACR. The independent association of both CKD measures with elevated cfPWV remained consistent after adjusting for additional confounders (ORs of elevated cfPWV were 1.09 [95% CI, 1.01-1.18] per 15-mL/min/1.73m2 lower eGFR and 1.20 [95% CI, 1.07-1.33] per 4-fold higher ACR). Higher ACR was also associated with elevated hfPWV and haPWV (ORs per 4-fold higher ACR were 1.25 [95% CI, 1.12-1.39] for elevated hfPWV and 1.19 [95% CI, 1.06-1.33] for elevated haPWV). Lower eGFR was associated with lower odds of elevated baPWV and faPWV (ORs per 15-mL/min/1.73m2 lower eGFR were 0.92 [95% CI, 0.84-0.99] and 0.91 [95% CI, 0.85-0.99], respectively). LIMITATION: Unable to address temporality between CKD measures and arterial stiffness. CONCLUSIONS: Both lower eGFR and higher ACR are independently associated with measures of central arterial stiffness, with stronger associations for ACR over eGFR. Our findings suggest that central arterial stiffness may be an important pathophysiologic phenotype of vascular disease in CKD.
RATIONALE & OBJECTIVE: Arterial stiffness is suggested as a mediator of cardiorenal interaction. However, previous studies reported inconsistent associations between chronic kidney disease (CKD) and arterial stiffness and were limited by using either estimated glomerular filtration rate (eGFR) or albumin-creatinine ratio (ACR) and examining arterial stiffness at limited segments. STUDY DESIGN: Cross-sectional. SETTING & PARTICIPANTS: 3,424 Atherosclerosis in Communities (ARIC) Study participants aged 66 to 90 years during 2011 to 2013. PREDICTORS: eGFR and ACR. OUTCOME: Pulse wave velocity (PWV) at 6 segments: carotid-femoral (cfPWV), heart-carotid (hcPWV), and heart-femoral (hfPWV), reflecting central stiffness; heart-ankle (haPWV) and brachial-ankle (baPWV), representing both central and peripheral stiffness; and femoral-ankle (faPWV), indicating peripheral stiffness. ANALYTICAL APPROACH: Multiple linear and logistic regression models to quantify the associations of eGFR and ACR with continuous PWV and elevated PWV (in the highest quartile), respectively. RESULTS: After adjusting for age, sex, and race, higher cfPWV and hfPWV were consistently associated with lower eGFR and higher ACR. Higher haPWV and baPWV were also observed with higher ACR. The independent association of both CKD measures with elevated cfPWV remained consistent after adjusting for additional confounders (ORs of elevated cfPWV were 1.09 [95% CI, 1.01-1.18] per 15-mL/min/1.73m2 lower eGFR and 1.20 [95% CI, 1.07-1.33] per 4-fold higher ACR). Higher ACR was also associated with elevated hfPWV and haPWV (ORs per 4-fold higher ACR were 1.25 [95% CI, 1.12-1.39] for elevated hfPWV and 1.19 [95% CI, 1.06-1.33] for elevated haPWV). Lower eGFR was associated with lower odds of elevated baPWV and faPWV (ORs per 15-mL/min/1.73m2 lower eGFR were 0.92 [95% CI, 0.84-0.99] and 0.91 [95% CI, 0.85-0.99], respectively). LIMITATION: Unable to address temporality between CKD measures and arterial stiffness. CONCLUSIONS: Both lower eGFR and higher ACR are independently associated with measures of central arterial stiffness, with stronger associations for ACR over eGFR. Our findings suggest that central arterial stiffness may be an important pathophysiologic phenotype of vascular disease in CKD.
Authors: Luca Zanoli; Paolo Lentini; Marie Briet; Pietro Castellino; Andrew A House; Gerard M London; Lorenzo Malatino; Peter A McCullough; Dimitri P Mikhailidis; Pierre Boutouyrie Journal: J Am Soc Nephrol Date: 2019-04-30 Impact factor: 10.121
Authors: Lee Stoner; Michelle L Meyer; Anna Kucharska-Newton; Keeron Stone; Gabriel Zieff; Gaurav Dave; Simon Fryer; Daniel Credeur; James Faulkner; Kunihiro Matsushita; Timothy M Hughes; Hirofumi Tanaka Journal: J Hypertens Date: 2020-09 Impact factor: 4.844
Authors: Bernard Choi; Christian Crouzet; Wei Ling Lau; David H Cribbs; Mark J Fisher Journal: J Stroke Cerebrovasc Dis Date: 2021-03-11 Impact factor: 2.677
Authors: Ramachandran S Vasan; Meghan I Short; Teemu J Niiranen; Vanessa Xanthakis; Charles DeCarli; Susan Cheng; Sudha Seshadri; Gary F Mitchell Journal: J Am Heart Assoc Date: 2019-07-13 Impact factor: 5.501
Authors: Qing Hao; Rebecca F Gottesman; Ye Qiao; Li Liu; Richa Sharma; Elizabeth Selvin; Kunihiro Matsushita; Josef Coresh; Bruce A Wasserman Journal: Neurology Date: 2020-04-17 Impact factor: 9.910
Authors: Mark L Unruh; Soraya Arzhan; Harold I Feldman; Helen C Looker; Robert G Nelson; Thomas Faber; David Johnson; Linda Son-Stone; Vernon S Pankratz; Larissa Myaskovsky; Vallabh O Shah Journal: BMC Nephrol Date: 2020-07-22 Impact factor: 2.388